Case studies


Building forward-thinking digital and innovation capabilities

In 2015, Takeda Pharmaceutical Company, the largest pharmaceutical company in Japan, established a simple yet radical vision to advance the merging of science, digital, and insights to transform customer experience and improve patients’ lives. For Takeda, digital technology offers the opportunity to make a real difference in people’s lives, driving patient’s to be the CEOs of their health. As a result, the company is focused on transforming into a leader in digital health.

One of the first objectives was to identify ways to accelerate and foster innovation from within. To turn these ideas into reality, Deloitte brought together a team of pharmaceutical and digital experts who helped design four global digital initiatives. They aimed to increase digital maturity levels across Takeda’s global organisation, raise awareness about digital business opportunities, infuse external expert knowledge, and fuel internal innovative thinking by building a foundation for digital experimentation, where new ways of thinking and working can be discovered by testing and learning.

To bring this to life, Takeda held its first “Dragon’s Den” (entrepreneurs pitching their business ideas) to solicit digital patient- and customer-centric ideas from its employees in its Europe/Canada region. Deloitte helped Takeda evaluate the ideas, designed and ran a Digital Experiment Bootcamp to assist the chosen teams in developing their digital ideas into minimally viable prototypes, and brought deep industry and digital expertise to help Takeda assess the ideas’ potential for globalisation. Deloitte and Takeda have continued to work together as the experimentation process has been rolled out to Takeda’s Emerging Markets and in Japan.

Across the projects, Deloitte’s team in Switzerland collaborated closely with Deloitte colleagues from the US, Germany, Israel, Japan and Korea, leveraging both our global network and our digital innovation and start-up capabilities.

Now is a transformative time for pharma, thanks in large part to the digital and technological revolution of today, and how it is converging with our industry. We endeavour to embed digital into our collective DNA to make it core to everything we do at Takeda. Deloitte’s expertise in this field is key in helping us achieve our transformative journey.

— Bruno Villetelle, Chief Digital Officer, Takeda

This client story is from the Deloitte Switzerland Annual Review 2016

See more of our client stories

Building forward-thinking digital and innovation capabilities

Accelerating organic growth in a B2B environment

Philip Morris International (PMI) 
Embarking on an innovation learning journey

EFG International 
Comprehensive transaction support for landmark transformational Swiss private banking combination

General Electric 
Delivering a complex divestiture

Syngenta AG 
Business Transformation

J. Safra Sarasin Group 
Using advanced reporting and data analytics to provide added value

Swiss Customs Administration 
Developing a sustainable IT transformation roadmap

Strengthening Leadership in the Humanitarian Sector

Ascensia Diabetes Care Holdings 
Implementing a successful global structure

Société Générale Private Banking (Suisse) SA 
Delivering a distinctive audit through constant and open communication

Canton of Zurich 
Process optimisation and digitalisation for the school districts of Zurich

Visit our interactive Annual Review

Find out on how Deloitte is making an impact to our clients, our people and society.

Did you find this useful?